Cargando…
Pediatric Fibrinogen PART II—Overview of Indications for Fibrinogen Use in Critically Ill Children
Bleeding is frequently seen in critically ill children and is associated with increased morbidity and mortality. Fibrinogen is an essential coagulation factor for hemostasis and hypofibrinogenemia is an important risk factor for bleeding in pediatric and adult settings. Cryoprecipitate and fibrinoge...
Autores principales: | Crighton, Gemma Louise, Huisman, Elise J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097134/ https://www.ncbi.nlm.nih.gov/pubmed/33968851 http://dx.doi.org/10.3389/fped.2021.647680 |
Ejemplares similares
-
Pediatric Fibrinogen PART I—Pitfalls in Fibrinogen Evaluation and Use of Fibrinogen Replacement Products in Children
por: Huisman, Elise J., et al.
Publicado: (2021) -
Editorial: Hemostatic Challenges in Pediatric Critical Care Medicine
por: Crighton, Gemma L., et al.
Publicado: (2021) -
Fibrinogen, Fibrinogen-like 1 and Fibrinogen-like 2 Proteins, and Their Effects
por: Sulimai, Nurul H., et al.
Publicado: (2022) -
Overview of Plasma and Platelet Transfusions in Critically Ill Children
por: Kahn, Stacie, et al.
Publicado: (2020) -
Fibrinogen heterogeneity in horses
por: Russell, Elise B., et al.
Publicado: (2021)